32 results match your criteria: "Center for Research on Health and Social Care Management[Affiliation]"
Coal mining and coal use: the European perspective.
Lancet Planet Health
February 2019
Department of Mobility, Urban Quality, Public Works, Ecology, and Environment, Puglia Region, Bari 70100, Italy; Euro Mediterranean Scientific Biomedical Institute, Mesagne, Italy. Electronic address:
Decarbonisation, climate change, and human rights: a road map for the future of Puglia region.
Lancet Planet Health
February 2018
Geneva School of Diplomacy, Geneva, Switzerland; Center for Research on Health and Social care Management, CERGAS, Bocconi University, Milan, Italy.
Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study.
BMC Med
March 2018
Collaboration for Research Integrity and Transparency (CRIT), Yale Law School, 157 Church Street, 17th Floor, Suite 1, New Haven, CT, 06510, USA.
Background: The U.S. Food and Drug Administration (FDA) often approves new drugs based on trials that use surrogate markers for endpoints, which involve certain trade-offs and may risk making erroneous inferences about the medical product's actual clinical effect.
View Article and Find Full Text PDFDealing with Uncertainty and Accounting for Social Value Judgments in Assessments of Orphan Drugs: Evidence from Four European Countries.
Value Health
July 2017
Department of Social Policy, LSE Health, London School of Economics and Political Science, London, UK.
Objectives: To better understand the reasons for differences in reimbursement decisions for orphan drugs in four European countries that were not readily apparent from health technology assessment (HTA) reports and operating procedures.
Methods: Semistructured interviews with representatives of HTA bodies in England, Scotland, Sweden, and France were conducted. An interview topic guide was developed on the basis of findings from a systematic comparison of HTA decisions for 10 orphan drugs.
BRICS' role in global health and the promotion of universal health coverage: the debate continues.
Bull World Health Organ
June 2014
Center for Research on Health and Social Care Management, Bocconi University, Milan, Italy .
A framework to analyze hospital-wide patient flow logistics: evidence from an Italian comparative study.
Health Policy
April 2014
CERGAS, Center for Research on Health and Social Care Management, Bocconi University, Milano, Italy. Electronic address:
Through a comparative study of six Italian hospitals, the paper develops and tests a framework to analyze hospital-wide patient flow performance. The framework adopts a system-wide approach to patient flow management and is structured around three different levels: (1) the hospital, (2) the pipelines (possible patient journeys within the hospital) and (3) the production units (physical spaces, such as operating rooms, where service delivery takes places). The focus groups and the data analysis conducted within the study support that the model is a useful tool to investigate hospital-wide implications of patient flows.
View Article and Find Full Text PDFAn economic perspective on urinary tract infection: the "costs of resignation".
Clin Drug Investig
April 2013
Center for Research on Health and Social Care Management, Bocconi University, Via Roentgen, 1, 20136 Milan, Italy.
Background: Urinary tract infection (UTI) is a leading cause of morbidity in the female population, with high levels of prevalence and recurrence within 6 months.
Objectives: Our objective was to estimate annual costs and health resource utilization by women with UTIs, and the impact on quality of life (QoL) due to lower urinary tract symptoms (LUTS), vaginal pain and dyspareunia. The secondary objective was to estimate the cost per episode of cystitis in a subgroup of patients with recurrent UTIs.